Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

This study has been completed.
Information provided by (Responsible Party):
Prof. Dr. Thomas Otto, Lukas-Krankenhaus GmbH Identifier:
First received: December 22, 2010
Last updated: October 9, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)